[Translation] A multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of NT-002 capsules in the treatment of secondary hyperparathyroidism in Chinese patients with chronic kidney disease stage 3 or 4 and vitamin D insufficiency
主要目的:评估NT-002胶囊治疗CKD 3期或4期伴VDI的SHPT患者的有效性。
次要目的:评估NT-002胶囊治疗CKD 3期或4期伴VDI的SHPT患者的安全性。
[Translation] Primary objective: To evaluate the efficacy of NT-002 capsules in the treatment of SHPT patients with CKD stage 3 or 4 and VDI.
Secondary objective: To evaluate the safety of NT-002 capsules in the treatment of SHPT patients with CKD stage 3 or 4 and VDI.